Viewing StudyNCT00192179



Ignite Creation Date: 2024-05-05 @ 11:59 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00192179
Status: COMPLETED
Last Update Posted: 2012-03-02
First Post: 2005-09-12

Brief Title: A Phase II Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years
Sponsor: MedImmune LLC
Organization: MedImmune LLC

Organization Data

Organization: MedImmune LLC
Class: INDUSTRY
Study ID: D153-P526
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: MedImmune LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Raburn Mallory MD Sr Dir Clinical Development
Old Organization: MedImmune

Collaborators

Name Class
Wyeth is now a wholly owned subsidiary of Pfizer INDUSTRY